Breaking down the barriers in the management of INOCA: how can we do better in the diagnosis of coronary vasomotor disorders?

EuroIntervention

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.

Published: February 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725083PMC
http://dx.doi.org/10.4244/EIJ-E-21-00008DOI Listing

Publication Analysis

Top Keywords

breaking barriers
4
barriers management
4
management inoca
4
inoca better
4
better diagnosis
4
diagnosis coronary
4
coronary vasomotor
4
vasomotor disorders?
4
breaking
1
management
1

Similar Publications

To preserve barrier function, cell-cell junctions must dynamically remodel during cell shape changes. We have previously described a rapid tight junction repair pathway characterized by local, transient activation of RhoA, termed "Rho flares", which repair leaks in tight junctions via promoting local actomyosin-mediated junction remodeling. In this pathway, junction elongation is a mechanical trigger that initiates RhoA activation through an influx of intracellular calcium and recruitment of p115RhoGEF.

View Article and Find Full Text PDF

Modulating the structure of Cu in CuX/CNTs hollow tetrakaidecahedron to enhance high-efficiency HO production.

J Colloid Interface Sci

January 2025

School of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, China. Electronic address:

Regulation of active sites of electrocatalysts is critical in adjusting electronic structure and catalytic selectivity towards oxygen reduction reaction (ORR) to hydrogen peroxide (HO). Herein, the CuX/CNTs (X = Se, SSe, S) hollow tetrakaidecahedron catalysts were synthesized to facilitate the electrocatalytic reduction of O to HO. The introduction of S resulted in a shift from four-electron pathway on CuSe/CNTs to two-electron process on CuS/CNTs, ultimately leading to an enhancement in HO productivity.

View Article and Find Full Text PDF

Since decades after temozolomide was approved, no effective drugs have been developed. Undoubtedly, blood-brain barrier (BBB) penetration is a severe issue that should be overcome in glioblastoma multiforme (GBM) drug development. In this research, we were inspired by linezolid through structural modification with several bioactive moieties to achieve the desired brain delivery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!